{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:44:18Z","timestamp":1775061858408,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T00:00:00Z","timestamp":1251158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/sj.bjc.6605199","type":"journal-article","created":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T22:48:46Z","timestamp":1251240526000},"page":"774-781","source":"Crossref","is-referenced-by-count":60,"title":["MI-63: A novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53"],"prefix":"10.1038","volume":"101","author":[{"given":"J A","family":"Canner","sequence":"first","affiliation":[]},{"given":"M","family":"Sobo","sequence":"additional","affiliation":[]},{"given":"S","family":"Ball","sequence":"additional","affiliation":[]},{"given":"B","family":"Hutzen","sequence":"additional","affiliation":[]},{"given":"S","family":"DeAngelis","sequence":"additional","affiliation":[]},{"given":"W","family":"Willis","sequence":"additional","affiliation":[]},{"given":"A W","family":"Studebaker","sequence":"additional","affiliation":[]},{"given":"K","family":"Ding","sequence":"additional","affiliation":[]},{"given":"S","family":"Wang","sequence":"additional","affiliation":[]},{"given":"D","family":"Yang","sequence":"additional","affiliation":[]},{"given":"J","family":"Lin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,8,25]]},"reference":[{"key":"BF6605199_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1200\/JCO.2003.06.129","volume":"21","author":"JC Breneman","year":"2003","unstructured":"Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN, Crist WM (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21: 78\u201384","journal-title":"J Clin Oncol"},{"key":"BF6605199_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/BF03401562","volume":"1","author":"J Chen","year":"1995","unstructured":"Chen J, Lin J, Levine AJ (1995) Regulation of transcription functions of the p53 tumor suppressor by the MDM-2 oncogene. Mol Med 1: 142\u2013152","journal-title":"Mol Med"},{"key":"BF6605199_CR3","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1128\/MCB.16.5.2445","volume":"16","author":"J Chen","year":"1996","unstructured":"Chen J, Wu X, Lin J, Levine AJ (1996) mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 16: 2445\u20132452","journal-title":"Mol Cell Biol"},{"key":"BF6605199_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1541-7786.20.2.1","volume":"2","author":"P Chene","year":"2004","unstructured":"Chene P (2004) Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface. Mol Cancer Res 2: 20\u201328","journal-title":"Mol Cancer Res"},{"key":"BF6605199_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27\u201355","journal-title":"Adv Enzyme Regul"},{"key":"BF6605199_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/phrs.1997.0269","volume":"37","author":"M Cinelli","year":"1998","unstructured":"Cinelli M, Magnelli L, Chiarugi V (1998) Redundant down-regulation pathways for p53. Pharmacol Res 37: 83\u201385","journal-title":"Pharmacol Res"},{"key":"BF6605199_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","volume":"13","author":"W Crist","year":"1995","unstructured":"Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R et al (1995) The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13: 610\u2013630","journal-title":"J Clin Oncol"},{"key":"BF6605199_CR8","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1158\/0008-5472.CAN-05-4578","volume":"66","author":"E Davicioni","year":"2006","unstructured":"Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche TJ, Anderson MJ (2006) Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res 66: 6936\u20136946","journal-title":"Cancer Res"},{"key":"BF6605199_CR9","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1021\/jm051122a","volume":"49","author":"K Ding","year":"2006","unstructured":"Ding K, Lu Y, Nikolovska-Coleska Z, Wang G, Qiu S, Shangary S, Gao W, Qin D, Stuckey J, Krajewski K, Roller PP, Wang S (2006) Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. J Med Chem 49: 3432\u20133435","journal-title":"J Med Chem"},{"key":"BF6605199_CR10","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/sj.onc.1202200","volume":"17","author":"SY Fuchs","year":"1998","unstructured":"Fuchs SY, Adler V, Buschmann T, Wu X, Ronai Z (1998) Mdm2 association with p53 targets its ubiquitination. Oncogene 17: 2543\u20132547","journal-title":"Oncogene"},{"key":"BF6605199_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.semcancer.2004.04.003","volume":"14","author":"S Haupt","year":"2004","unstructured":"Haupt S, Haupt Y (2004) Manipulation of the tumor suppressor p53 for potentiating cancer therapy. Semin Cancer Biol 14: 244\u2013252","journal-title":"Semin Cancer Biol"},{"key":"BF6605199_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","volume":"420","author":"R Honda","year":"1997","unstructured":"Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25\u201327","journal-title":"FEBS Lett"},{"key":"BF6605199_CR13","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1158\/1078-0432.CCR-08-0150","volume":"14","author":"RJ Jones","year":"2008","unstructured":"Jones RJ, Chen Q, Voorhees PM, Young KH, Bruey-Sedano N, Yang D, Orlowski RZ (2008) Inhibition of the p53 E3 ligase HDM-2 induces apoptosis and DNA damage--independent p53 phosphorylation in mantle cell lymphoma. Clin Cancer Res 14: 5416\u20135425","journal-title":"Clin Cancer Res"},{"key":"BF6605199_CR14","first-page":"143","volume":"149","author":"J Keleti","year":"1996","unstructured":"Keleti J, Quezado MM, Abaza MM, Raffeld M, Tsokos M (1996) The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein. Am J Pathol 149: 143\u2013151","journal-title":"Am J Pathol"},{"key":"BF6605199_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/sj.bjc.6602164","volume":"91","author":"C Klein","year":"2004","unstructured":"Klein C, Vassilev LT (2004) Targeting the p53-MDM2 interaction to treat cancer. Br J Cancer 91: 1415\u20131419","journal-title":"Br J Cancer"},{"key":"BF6605199_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1126\/science.274.5289.948","volume":"274","author":"PH Kussie","year":"1996","unstructured":"Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948\u2013953","journal-title":"Science"},{"key":"BF6605199_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/08977190500196218","volume":"23","author":"Y Levav-Cohen","year":"2005","unstructured":"Levav-Cohen Y, Haupt S, Haupt Y (2005) Mdm2 in growth signaling and cancer. Growth Factors 23: 183\u2013192","journal-title":"Growth Factors"},{"key":"BF6605199_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1101\/gad.8.10.1235","volume":"8","author":"J Lin","year":"1994","unstructured":"Lin J, Chen J, Elenbaas B, Levine AJ (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev 8: 1235\u20131246","journal-title":"Genes Dev"},{"key":"BF6605199_CR19","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/nar\/26.15.3453","volume":"26","author":"J Momand","year":"1998","unstructured":"Momand J, Jung D, Wilczynski S, Niland J (1998) The MDM2 gene amplification database. Nucleic Acids Res 26: 3453\u20133459","journal-title":"Nucleic Acids Res"},{"key":"BF6605199_CR20","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1200\/JCO.1995.13.8.2123","volume":"13","author":"AS Pappo","year":"1995","unstructured":"Pappo AS, Shapiro DN, Crist WM, Maurer HM (1995) Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13: 2123\u20132139","journal-title":"J Clin Oncol"},{"key":"BF6605199_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00043426-200105000-00008","volume":"23","author":"RB Raney","year":"2001","unstructured":"Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS, Qualman SJ, Wiener ES, Maurer HM, Crist WM (2001) Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23: 215\u2013220","journal-title":"J Pediatr Hematol Oncol"},{"key":"BF6605199_CR22","volume-title":"Cancer incidence and survival among children and adolescents : United States SEER program 1975\u20131995 \/[edited by Lynn A. Gloecker Ries . et al]","author":"LAG Ries","year":"1999","unstructured":"Ries LAG, SEER Program (National Cancer Institute (US)) (1999) Cancer incidence and survival among children and adolescents : United States SEER program 1975\u20131995 \/[edited by Lynn A. Gloecker Ries . et al]. SEER pediatric monograph. National Cancer Institute, SEER Program: Bethesda, MD"},{"key":"BF6605199_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/modpathol.3800101","volume":"17","author":"Y Takahashi","year":"2004","unstructured":"Takahashi Y, Oda Y, Kawaguchi K, Tamiya S, Yamamoto H, Suita S, Tsuneyoshi M (2004) Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Mod Pathol 17: 660\u2013669","journal-title":"Mod Pathol"},{"key":"BF6605199_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z","volume":"35","author":"AC Taylor","year":"2000","unstructured":"Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, Thayer MJ, Houghton PJ, Harris LC (2000) P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol 35: 96\u2013103","journal-title":"Med Pediatr Oncol"},{"key":"BF6605199_CR25","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1073\/pnas.0507493103","volume":"103","author":"C Tovar","year":"2006","unstructured":"Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H, Zhao X, Vu BT, Qing W, Packman K, Myklebost O, Heimbrook DC, Vassilev LT (2006) Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci USA 103: 1888\u20131893","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605199","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T13:08:56Z","timestamp":1685106536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BF6605199"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605199","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]}}}